NORITNIELSEN ApS PHARMASOURCE: Financial statements 2024
CVR: 33266707
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
NORITNIELSEN ApS PHARMASOURCE (CVR 33266707) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 374,773 and a net result of DKK 22,170 compared with DKK 77,974 the year before. That is a decrease of 58.1% compared with the year before. Equity in the 2024 report amounted to DKK 180,144. The solvency ratio was 42.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 374,773
- Profit/Loss
- DKK 22,170
- Equity
- DKK 180,144
- Total Assets
- DKK 424,999
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 375K | 22K | 180K | 1 |
| 2023 | - | 894K | 78K | 158K | 0 |
| 2022 | - | 3.6M | 1.5M | 2.1M | 2 |
| 2021 | - | 3M | 837K | 2.1M | 2 |
| 2020 | - | 2.9M | 805K | 2.1M | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NORITNIELSEN ApS PHARMASOURCE has published its annual report for 2023. Gross profit came to DKK 894,277, and the net result was DKK 77,974.
About NORITNIELSEN ApS PHARMASOURCE
NORITNIELSEN ApS PHARMASOURCE was a Danish company of the type Anpartsselskab based in Farum, founded in 2010. The company has been dissolved on 1 May 2025. The company was registered under the industry Virksomhedsrådgivning og andre rådgivningsaktiviteter. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 374,773 and a net result of DKK 22,170 compared with DKK 77,974 the year before. Equity in the 2024 report amounted to DKK 180,144.